Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Prospective BASECAMP-1 experience in patients with gastrointestinal (GI) cancer: Identifying patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) for a future therapeutic trial exploiting LOH as a tumor vulnerability.
Presenter
J. Randolph Hecht, MD
David Geffen School of Medicine at UCLA
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Clinical Trial Registration Number
NCT04981119
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 209)
DOI
10.1200/JCO.2023.41.4_suppl.209
Abstract #
209
Poster Bd #
L11
Abstract Disclosures
Similar Videos & Slides
Videos & Slides
2022 ASCO Annual Meeting
BASECAMP-1: Leveraging human leukocyte antigen (HLA) loss of heterozygosity (LOH) in solid tumors by next-generation sequencing (NGS) to identify patients with relapsed solid tumor for future logic-gated Tmod CAR T-cell therapy.
Speaker: Diane M. Simeone, MD
Videos & Slides
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Human leukocyte antigen expression in paired primary lung lesions and brain metastases in non-small cell lung cancer.
Speaker: Jarrett Failing, MD
Videos & Slides
2024 ASCO Breakthrough
Unsupervised clustering of brain tumor leukocytes to reveal atypical lymphoid cell subsets.
Speaker: Ismaïl Hermelo, MSc
Speaker: Imane H. El Dika, MD